"Designing Growth Strategies is in our DNA"

Multiple Myeloma Market Size, Share & Industry Analysis, By Drug Class (Immunomodulators, Proteasome Inhibitor, Anti-CD38 Monoclonal Antibody, Alkylating Agents, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies), and Regional Forecast, 2019-2026

Region : Global | Format: PDF | Report ID: FBI102693

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Multiple Myeloma - by Key Countries - 2018
    2. Pipeline Analysis
    3. Key Industry Developments
    4. Regulatory Scenario, by Key Regions
    5. Analysis Of Economic Burden of Multiple Myeloma Treatment
    6. New Product Launches
    7. Overview of Emerging Treatments for Multiple Myeloma
  5. Global Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Immunomodulators
      2. Proteasome Inhibitor
      3. Anti-CD38 Monoclonal Antibody
      4. Alkylating Agents
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Immunomodulators
      2. Proteasome Inhibitor
      3. Anti-CD38 Monoclonal Antibody
      4. Alkylating Agents
      5. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Immunomodulators
      2. Proteasome Inhibitor
      3. Anti-CD38 Monoclonal Antibody
      4. Alkylating Agents
      5. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis – By Country/ sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia pacific Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Immunomodulators
      2. Proteasome Inhibitor
      3. Anti-CD38 Monoclonal Antibody
      4. Alkylating Agents
      5. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis – By Country/ sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Immunomodulators
      2. Proteasome Inhibitor
      3. Anti-CD38 Monoclonal Antibody
      4. Alkylating Agents
      5. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis – By Country/ sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Immunomodulators
      2. Proteasome Inhibitor
      3. Anti-CD38 Monoclonal Antibody
      4. Alkylating Agents
      5. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
    4. Market Analysis – By Country/ sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2017)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Takeda Pharmaceutical Company Limited
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Novartis AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Teva Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Bristol Myers Squibb Company
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Amgen Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. ONO PHARMACEUTICAL CO., LTD.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Janssen Pharmaceuticals, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Genentech, Inc. (F. Hoffmann-La Roche Ltd)
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. CELGENE CORPORATION (Bristol Myers Squibb Company)
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. AbbVie Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      11. Sanofi
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      12. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendation
Read Less

Figure 1:  Global Multiple Myeloma Market Revenue Breakdown (US$ Bn, %) by Region, 2018 & 2026

Figure 2:  Global Multiple Myeloma Market Value Share (%), by Drug Class, 2018 & 2026

Figure 3:  Global Multiple Myeloma Market Forecast (US$ Bn), by Immunomodulators, 2015-2026

Figure 4:  Global Multiple Myeloma Market Forecast (US$ Bn), by Proteasome Inhibitor, 2015-2026

Figure 5:  Global Multiple Myeloma Market Forecast (US$ Bn), by Anti-CD38 Monoclonal Antibody, 2015-2026

Figure 6:  Global Multiple Myeloma Market Forecast (US$ Bn), by Alkylating Agents, 2015-2026

Figure 7:  Global Multiple Myeloma Market Forecast (US$ Bn), by Others, 2015-2026

Figure 8:  Global Multiple Myeloma Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 9:  Global Multiple Myeloma Market Forecast (US$ Bn), by Hospital Pharmacies, 2015-2026

Figure 10:  Global Multiple Myeloma Market Forecast (US$ Bn), by Retail Pharmacies & Drug Stores, 2015-2026

Figure 11:  Global Multiple Myeloma Market Forecast (US$ Bn), by Online Pharmacies, 2015-2026

Figure 12:  Global Multiple Myeloma Market Value (US$ Bn), by Region, 2018 & 2026

Figure 13:  North America Multiple Myeloma Market Value (US$ Bn), by Drug Class, 2018 & 2026

Figure 14:  North America Multiple Myeloma Market Value Share (%), by Drug Class, 2018

Figure 15:  North America Multiple Myeloma Market Value (US$ Bn), by Distribution Channel, 2018 & 2026

Figure 16:  North America Multiple Myeloma Market Value Share (%), by Distribution Channel, 2018

Figure 17:  North America Multiple Myeloma Market Value (US$ Bn), By Country, 2018 & 2026

Figure 18:  North America Multiple Myeloma Market Value Share (%), By Country, 2018

Figure 19:  Europe Multiple Myeloma Market Value (US$ Bn), by Drug Class, 2018 & 2026

Figure 20:  Europe Multiple Myeloma Market Value Share (%), by Drug Class, 2018

Figure 21:  Europe Multiple Myeloma Market Value (US$ Bn), by Distribution Channel, 2018 & 2026

Figure 22:  Europe Multiple Myeloma Market Value Share (%), by Distribution Channel, 2018

Figure 23:  Europe Multiple Myeloma Market Value (US$ Bn), By Country/ Sub-region, 2018 & 2026

Figure 24:  Europe Multiple Myeloma Market Value Share (%), By Country/ Sub-region, 2018

Figure 25:  Asia Pacific Multiple Myeloma Market Value (US$ Bn), by Drug Class, 2018 & 2026

Figure 26:  Asia Pacific Multiple Myeloma Market Value Share (%), by Drug Class, 2018

Figure 27:  Asia Pacific Multiple Myeloma Market Value (US$ Bn), by Distribution Channel, 2018 & 2026

Figure 28:  Asia Pacific Multiple Myeloma Market Value Share (%), by Distribution Channel, 2018

Figure 29:  Asia Pacific Multiple Myeloma Market Value (US$ Bn), By Country/ Sub-region, 2018 & 2026

Figure 30:  Asia Pacific Multiple Myeloma Market Value Share (%), By Country/ Sub-region, 2018

Figure 31:  Latin America Multiple Myeloma Market Value (US$ Bn), by Drug Class, 2018 & 2026

Figure 32:  Latin America Multiple Myeloma Market Value Share (%), by Drug Class, 2018

Figure 33:  Latin America Multiple Myeloma Market Value (US$ Bn), by Distribution Channel, 2018 & 2026

Figure 34:  Latin America Multiple Myeloma Market Value Share (%), by Distribution Channel, 2018

Figure 35:  Latin America Multiple Myeloma Market Value (US$ Bn), By Country/ Sub-region, 2018 & 2026

Figure 36:  Latin America Multiple Myeloma Market Value Share (%), By Country/ Sub-region, 2018

Figure 37:  Middle East & Africa Multiple Myeloma Market Value (US$ Bn), by Drug Class, 2018 & 2026

Figure 38:  Middle East & Africa Multiple Myeloma Market Value Share (%), by Drug Class, 2018

Figure 39:  Middle East & Africa Multiple Myeloma Market Value (US$ Bn), by Distribution Channel, 2018 & 2026

Figure 40:  Middle East & Africa Multiple Myeloma Market Value Share (%), by Distribution Channel, 2018

Figure 41:  Middle East & Africa Multiple Myeloma Market Value (US$ Bn), By Country/ Sub-region, 2018 & 2026

Figure 42:  Middle East & Africa Multiple Myeloma Market Value Share (%), By Country/ Sub-region, 2018

Figure 43:  Global Multiple Myeloma Market Share (%), By Company, 2018

Table 1:  Global Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Drug Class, 2015–2026

Table 2:  Global Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015–2026

Table 3:  Global Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Region, 2015-2026

Table 4:  North America Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Drug Class, 2015-2026

Table 5:  North America Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015-2026

Table 6:  North America Multiple Myeloma Market Revenue (US$ Bn) Forecast, By Country, 2015-2026

Table 7:  Europe Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Drug Class, 2015-2026

Table 8:  Europe Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015-2026

Table 9:  Europe Multiple Myeloma Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2015-2026

Table 10:  Asia Pacific Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Drug Class, 2015-2026

Table 11:  Asia Pacific Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015-2026

Table 12:  Asia Pacific Multiple Myeloma Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2015-2026

Table 13:  Latin America Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Drug Class, 2015-2026

Table 14:  Latin America Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015-2026

Table 15:  Latin America Multiple Myeloma Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2015-2026

Table 16:  Middle East & Africa Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Drug Class, 2015-2026

Table 17:  Middle East & Africa Multiple Myeloma Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2015-2026

Table 18:  Middle East & Africa Multiple Myeloma Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2015-2026

Booklet
  • Apr, 2020
  • 2018
  • 2015-2017
  • 110

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Compare Licenses Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Related Reports

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X